BioCryst Pharmaceuticals Inc (BCRX.OQ)

BCRX.OQ on NASDAQ Stock Exchange Global Select Market

11.42USD
28 Aug 2015
Change (% chg)

$0.21 (+1.87%)
Prev Close
$11.21
Open
$11.10
Day's High
$11.43
Day's Low
$11.04
Volume
174,998
Avg. Vol
282,825
52-wk High
$16.80
52-wk Low
$7.85

BCRX.OQ

Chart for BCRX.OQ

About

BioCryst Pharmaceuticals, Inc. (BioCryst) is a biotechnology company. The Company designs, optimizes and develops small molecule drugs that block enzymes involved in the pathogenesis of diseases. The Company focuses on the treatment rare diseases. The Company uses X-ray crystallography, computer modeling of molecular structures... (more)

Overall

Beta: 2.63
Market Cap(Mil.): $836.39
Shares Outstanding(Mil.): 73.24
Dividend: --
Yield (%): --

Financials

  BCRX.OQ Industry Sector
P/E (TTM): -- 70.22 36.13
EPS (TTM): -0.43 -- --
ROI: -33.43 0.47 14.83
ROE: -36.91 0.34 15.69
Search Stocks

BioCryst wins US contract to continue Ebola drug development

- BioCryst Pharmaceuticals Inc said it won a U.S. government contract to continue development of its potential treatment for Ebola and other viral diseases.

31 Mar 2015

UPDATE 1-BioCryst wins US contract to continue Ebola drug development

March 31 - BioCryst Pharmaceuticals Inc said it won a U.S. government contract to continue development of its potential treatment for Ebola and other viral diseases.

31 Mar 2015

BioCryst Pharma wins federal contract to continue making Ebola drug

March 31 - BioCryst Pharmaceuticals Inc said it won a U.S. government contract for the continued development of its potential treatment for viral diseases, including Ebola.

31 Mar 2015

Competitors

  Price Chg
DAIICHI SANKYO COMPANY, LIMITED (4568.T) ¥2,310 +57.00
Eisai Co., Ltd (4523.T) ¥8,045 +331.00
Roche Holding Ltd. (ROG.VX) CHF263.20 -3.80
GlaxoSmithKline plc (GSK.L) 1,340.50p +9.50
Shire PLC (SHP.L) 5,025.00p +10.00
Shire PLC (3159084.L) -- --

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider : ValuEngine, Inc.
$25.00
Provider : Stock Traders Daily
$20.00
Provider : Reuters Investment Profile
$20.00
Provider : Thomson Reuters Stock Report
$25.00
Provider : New Constructs, LLC
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks